MarketInOut Stock Screener Log In | Sign Up
 

Lakewood-Amedex Biotherapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Lakewood-Amedex Biotherapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization0.7228 mln
Float1.58 mln

Piotroski F-Score

1 / 9
Very weak

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.02
Debt-free

ROE

-403
Deeply negative

ROA

-449
Deeply negative

Business Description

Lakewood-Amedex Biotherapeutics Inc. is a Florida-based company focused on creating new medicines to fight bacterial infections. Its lead group of treatments, called Bisphosphocins, targets a wide range of infections in areas such as the skin, bladder, and lungs. The company is currently running a mid-stage clinical trial for Nu-3, a topical treatment designed to address infected foot wounds in diabetic patients.

Key Fundamentals

EPS-9.57
ROE-403
ROIC-388
ROA-449
Interest Cover-58.40
EBITDA, mln-7.10
EV / EBITDA0.32
EV / EBIT0.31

Quote Details

Last 0.31
Change -0.1795 (-36.67%)
Open 0.3463
Volume 39,082,496
Turnover 12,115,574
Average Volume 4,132,345

Financial Ratios

Leverage Ratio1.15
Current Ratio7.70
Price / Book0.47
Price / Tangible Book0.47
Debt / Equity0.02

Financial Strength

Piotroski F-Score 1 / 9
Short Ratio0.05
Short % of Float10.72

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -46.55% 0 / 100   
1 Month -83.06% 0 / 100   
2 Months -83.94% 1 / 100   
6 Months -99.58% 0 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog